logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yingyi Liu

Department of Hepatobiliary
H指数:17
被引数:1,171

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study

更正：人胆汁脂质组学分析能够将胆管癌与良性胆管疾病区分开，具有高特异性和高灵敏度：一项前瞻性描述性研究

British Journal of Cancer
IF6.8
2025-10-210
OA
Fu-Sheng Liu; Ying-Yi Liu; Shi-Kun Zhang; Jun-Yu Zhou; Jing-Hua Li; Xiao-mian Li; Ming-He Zhang; Xiao-Yu Pan; Yi-Bo Chai; Wei-Xian Fang; Tao Yuan; Xu-Yun Yan; Xi Chen; Tian-Gen Wu; Wei-Jie Ma; Bo Liao; Ping Jiang; Wei-Hua Huang; Song-Mei Liu; Shan Guo; Yu-Feng Yuan
Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study

人胆汁的脂质组学分析能够高特异性和高灵敏度地区分胆管癌与良性胆管疾病：一项前瞻性描述性研究

British Journal of Cancer
IF6.8
2025-09-020
OAAI
Fu-Sheng Liu; Ying-Yi Liu; Shi-Kun Zhang; Jun-Yu Zhou; Jing-Hua Li; Xiao-mian Li; Ming-He Zhang; Xiao-Yu Pan; Yi-Bo Chai; Wei-Xian Fang; Tao Yuan; Xu-Yun Yan; Xi Chen; Tian-Gen Wu; Wei-Jie Ma; Bo Liao; Ping Jiang; Wei-Hua Huang; Song-Mei Liu; Shan Guo; Yu-Feng Yuan
In-beam gamma rays of CSNS Back-n characterized by black resonance filter
NUCLEAR SCIENCE AND TECHNIQUES
IF3.8
2024-09-181
PRE
Wang, Jin-Cheng; Ren, Jie; Jiang, Wei; Ruan, Xi-Chao; Liu, Ying-Yi; Yang, Hao-Lan; Xu, Kuo-Zhi; Pan, Xin-Yi; Sun, Qi; Bao, Jie; Huang, Han-Xiong; Bai, Hao-Fan; Bai, Jiang-Bo; Cao, Ping; Chen, Qi-Ping; Chen, Yong-Hao; Duan, Wen-Hao; Fan, An-Chuan; Fan, Rui-Rui; Feng, Chang-Qing; Gu, Min-Hao; Han, Chang-Cai; Han, Zi-Jie; He, Guo-Zhu; He, Yong-Cheng; Hong, Yang; Hu, Yi-Wei; Jiang, Zhi-Jie; Kang, Ling; Lan, Chang-Lin; Li, Bo; Li, Feng; Li, Qiang; Li, Xiao; Li, Yang; Liu, Jie; Liu, Rong; Liu, Shu-Bin; Liu, Yi-Na; Luan, Guang-Yuan; Ning, Chang-Jun; Qiu, Yi-Jia; Ren, Wen-Kai; Ren, Zhi-Zhou; Song, Zhao-Hui; Sun, Kang; Tan, Zhi-Xin; Tang, Jing-Yu; Tang, Sheng-Da; Wang, Li-Jiao; Wang, Peng-Cheng; Wang, Zhao-Hui; Wen, Zhong-Wei; Wu, Xiao-Guang; Wu, Xuan; Wu, Ze-Peng; Xia, Cong; Xie, Li-Kun; Yi, Han; Yu, Tao; Yu, Yong-Ji; Zhang, Guo-Hui; Zhang, Hang-Chang; Zhang, Qi-Wei; Zhang, Xian-Peng; Zhang, Yu-Liang; Zhang, Zhi-Yong; Zhao, Mao-Yuan; Zhou, Zhi-Hao; Zhu, Ke-Jun; Zou, Chong
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)

在中度至重度特应性皮炎中，从dupilumab转换为upadacitinib与连续upadacitinib的疗效和安全性: 来自3期，随机，对照试验的开放标签扩展的结果 (抬头)

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
IF11.8
2023-09-0115
OA
Blauvelt, Andrew; Ladizinski, Barry; Prajapati, Vimal H.; Laquer, Vivian; Fischer, Alison; Eisman, Samantha; Hu, Xiaofei; Wu, Tianshuang; Calimlim, Brian M.; Kaplan, Blair; Liu, Yingyi; Teixeira, Henrique D.; Liu, John; Eyerich, Kilian

研究方向

暂未获取到该数据
Y
Yufeng Yuan
H 指数:41论文数:212被引数:9,097
F
Fusheng Liu
H 指数:10论文数:60被引数:466
张忠林 封面图
张忠林
H 指数:43论文数:235被引数:7,961
W
Weijie Ma
H 指数:24论文数:96被引数:2,061
杨
杨红建
H 指数:34论文数:208被引数:4,044
J
Jinghua Li
H 指数:10论文数:37被引数:482
L
Liangkang Lv
H 指数:10论文数:22被引数:255
F
Fengliang Xiong
H 指数:5论文数:17被引数:58
Y
Ye Yao
H 指数:38论文数:218被引数:5,101
柏峻 封面图
柏峻
H 指数:25论文数:141被引数:1,971